-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Ingevity, Lowers Price Target to $72

Benzinga·11/20/2026 16:31:42
Listen to the news
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and lowers the price target from $85 to $72.